Regeneron Pharmaceuticals, Inc. (REGN)
828.72
-5.32
(-0.64%)
USD |
NASDAQ |
Aug 24, 16:00
834.55
+5.83
(+0.70%)
After-Hours: 20:00
Regeneron Pharmaceuticals Debt to Equity Ratio : 0.0854 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0854 |
| March 31, 2026 | 0.0861 |
| December 31, 2025 | 0.0951 |
| September 30, 2025 | 0.0874 |
| June 30, 2025 | 0.0904 |
| March 31, 2025 | 0.092 |
| December 31, 2024 | 0.1001 |
| September 30, 2024 | 0.0922 |
| June 30, 2024 | 0.0959 |
| March 31, 2024 | 0.1002 |
| December 31, 2023 | 0.1041 |
| September 30, 2023 | 0.1085 |
| June 30, 2023 | 0.1125 |
| March 31, 2023 | 0.115 |
| December 31, 2022 | 0.1192 |
| September 30, 2022 | 0.126 |
| June 30, 2022 | 0.1305 |
| March 31, 2022 | 0.1356 |
| December 31, 2021 | 0.1438 |
| September 30, 2021 | 0.1564 |
| June 30, 2021 | 0.1783 |
| March 31, 2021 | 0.2252 |
| December 31, 2020 | 0.2445 |
| September 30, 2020 | 0.2661 |
| June 30, 2020 | 0.2447 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0589 |
| December 31, 2019 | 0.0644 |
| September 30, 2019 | 0.0678 |
| June 30, 2019 | 0.0729 |
| March 31, 2019 | 0.0752 |
| December 31, 2018 | 0.0809 |
| September 30, 2018 | 0.0899 |
| June 30, 2018 | 0.0982 |
| March 31, 2018 | 0.1073 |
| December 31, 2017 | 0.1145 |
| September 30, 2017 | 0.1161 |
| June 30, 2017 | 0.127 |
| March 31, 2017 | 0.1454 |
| December 31, 2016 | 0.1076 |
| September 30, 2016 | 0.0851 |
| June 30, 2016 | 0.0887 |
| March 31, 2016 | 0.0962 |
| December 31, 2015 | 0.0993 |
| September 30, 2015 | 0.1198 |
| June 30, 2015 | 0.1162 |
| March 31, 2015 | 0.159 |
| December 31, 2014 | 0.18 |
| September 30, 2014 | 0.2215 |
| June 30, 2014 | 0.2186 |
| March 31, 2014 | 0.2402 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Gilead Sciences, Inc. | 2.219 |
| AbbVie, Inc. | -11.93 |
| Vertex Pharmaceuticals, Inc. | 0.0977 |
| Amgen, Inc. | 4.903 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 41.73B |
| Total Liabilities (Quarterly) | 10.02B |
| Shareholders Equity (Quarterly) | 31.71B |
| Current Ratio | 3.335 |
| Net Debt Paydown Yield | -0.00% |